IART - Integra LifeSciences Holdings
Integra LifeSciences Holdings Logo

IART - Integra LifeSciences Holdings

https://www.integralife.com
Sell Momentum: Bearish
Recent News
Powered by Alpha Vantage
Bullish
Integra LifeSciences Leadership to Present at Wells Fargo and Morgan Stanley Healthcare Investor Conferences - Integra Lifesciences ( NASDAQ:IART )
Benzinga • 2 weeks, 2 days ago • score: 0.61
PRINCETON, N.J., Aug. 29, 2025 ( GLOBE NEWSWIRE ) -- Integra LifeSciences Holdings Corporation IART, a leading global medical technology company, today announced that chief executive officer Mojdeh Poul and chief financial officer Lea Knight will present at two upcoming investor healthcare ...
AI Tools
Key Metrics
Trend: Range-Bound
As of 2025-09-10 (Snapshot)

Integra LifeSciences Holdings Corporation develops, manufactures, and markets surgical implants and medical instruments for use in neurosurgery, limb reconstruction, orthopedics, and general surgery. The company is headquartered in Princeton, New Jersey.

52W High
$27.13
52W Low
$11.06
MA Status:
50D: Above 200D: Below
Beta (~1 neutral, <0.9 lower risk)
1.20
Valuation
Attractive
As of 2025-06-30 (Overview)
Trailing P/E (<15 better)
N/A
Forward P/E (<15 better)
6.45
EV/EBITDA (<8 favorable)
14.27
EV/Revenue (<3 favorable)
1.85
P/S (TTM) (<3 favorable)
0.77
P/B (<3 favorable)
1.20
Ownership
Institution‑heavy
Source: Overview
Insiders (1–5% typical)
13.97%
Institutions (25–75% balanced)
95.24%
Shares Outstanding
77,911,000
Float
59,271,000
Dividend Yield (2–6% sweet spot)
N/A
Ex‑Dividend Date
N/A
Income & Growth
Profitability: Weak
As of 2025-06-30 (Overview)
Revenue (TTM)
1,621,738,000
Gross Profit (TTM)
932,820,000
EPS (TTM)
-6.54
Profit Margin (>10% good)
-0.31%
Operating Margin (TTM) (higher better)
0.08%
ROE (TTM) (>15% strong)
-0.39%
EPS YoY (Quarterly) (>10% good)
0.00
Revenue YoY (Quarterly) (>8% good)
-0.01
Momentum
Bearish momentum
Value
0.6227
Previous
0.7012
Trend
Falling
Signal Cross
No cross
As of
Sep. 12, 2025